IL6 and myocardial ischemia: In another small study of 33 nondiabetic patients with IHD, de Mello et al. reported a significant positive association between serum interleukin-6 concentrations and total plasma ceramides [14], thus suggesting that ceramides may contribute to triggering systemic low-grade inflammation in IHD.